AMGN trade ideas
Based off past years of performanceThis seems to be a good stock to hold for the long term. It has high dividends and pretty stable growth. As of now, it is in my watchlist as I am hoping for a lower point to buy-in $(220-230) range but more likely $230 as I do not want to miss this stock.
$AMGN Amgen Breakout Target $280
Huge breakout today which stalled at Fibonacci extension targets
May get a slight pullback but long term target is in the $280 zone
BUY To AMGENHello traders, AMGEN is on a bullish slant, large volume of sales made in recent days. it can break the trend line and the consolidation zone.
Please LIKE & FOLLOW, thank you!
Inverse Head & ShouldersFirst time on putting an idea on here..so please bear with me (o:
Entry: 235
Stop: Below 224
Target 1: 270 to 279
Target 2: 307 to 327
Good luck!
Steady growth and good dividendndsSeem to have a good track record, especially by increasing dividends annually makes me interested in buying in once/ if it hits 200
AMGN Setting to Try 52 Week High AgainAfter a price rejection yet again at the 52 week high at the $243.60 range in May, we see a sell off and now the price is being supported at $219.40. It could also be shorts covering that is forming the consolidation. Stock is also oversold, according to the Stoch RSI. This could be a good entry point to go long and test the 52 week resistance again.
AMGNBased on my analysis:
1. AMGN formed a double bottom (May 20-26).
2. Breakout the neckline with a high volume.
3. Stochastic shows an upward price bias.
4. Traders are advised to take profit at the price level of (1) 231.60 USD or (2) 234-236 USD
Syeikh Hafiz
Stock Market Analyst
$AMGN - High risk high reward$AMGN
Massive inverse head and shoulders if you look at the bigger picture.
Monster of a biotech company so would consider this a high risk, high reward play especially with options.
Its been beaten down after multiple attempts of breaking out.
Play it safe:
Buy after 244 (confirm IHS breakout) & stop loss @ 240
Take on risk:
Limit buy: $237
Limit sell: 260
Stop loss: $224
AMGNHeikin Ashi Candlesticks - not yet a green week, but encouraging long tail.
2 std dev. regression channel
Look at this if you are looking for a good SHORT opportunity!Classic DOUBLE TOP pattern!
No need to explain!
AMGN Long based on earnings and technicalsAMGN just beat earning and has strong technical, so I will be going long with a price target of 242.
AMGEN INC (AMGN), AMAZING LEVELS!!!Look at these Levels and how it works!
If we just use such places for trading you don't need to make a lot of trades per month.
I will post more such ideas with stock instruments if this post will get a lot of likes.
Before to trade my ideas make your own analysis.
Thanks for your support!
Is it a good time to short Amgen?Amgen has been cosonlidated in this bulish trend for more than two years. The author observed that the buyers were struggling to prop it up even more to a further breakout. AMGN is likely to fall onto the psychologcal line of 210 and a furthr space down to 200.
AMGN Risk of TopAMGN has a Flat Top Formation that is breaking to the downside during earnings season. Stocks with weaker earnings are under High Frequency Trader triggers to the downside. The weak run up reveals the large lot selling at this level.
Amgen Bull Flag: Just What the Doctor Ordered?Biotechnology stocks surged in the fourth quarter thanks to some takeovers and buyers returning to the health-care sector.
Amgen is the biggest of all the biotechs with $144 billion of market cap. It's also one of the few big names that's broken out to new highs. (Along with Vertex .)
AMGN's been climbing a wall of worry about competition since the summer. The flurry of good news began in June when its AMG 510 cancer compound successfully shrank lung tumors. Then, earnings beat in both July and October as its new biosimilar franchise surprised the naysayers.
Now's the first real pullback since breaking out. AMGN's bullish flag may create potential for a continuation move higher, with Friday's low of $236.24 as a level for risk management. The next earnings report is estimated for Jan. 28.
